Introduction: Management of hepatitis C virus (HCV) is rapidly changing as a result of new direct-acting antivirals (DAA). Sources of data: Several peer-reviewed papers featuring new DAAs are now available. Additionally, as new data are emerging so quickly, we also reviewed recent presentations at international congresses, published i
Hepatitis C virus (HCV) still represents a major public health threat, with a dramatic burden from b...
com The hepatitis C virus (HCV) has a significant medical and economic impact on societies around th...
ABSTRACT Hepatitis C is a global epidemic that affects over 150 million people. The global preval...
Introduction: Management of hepatitis C virus (HCV) is rapidly changing as a result of new direct-ac...
The hepatitis C virus (HCV) has a significant medical and economic impact on societies around the wo...
One of the most exciting developments in antiviral research has been the discovery of the direct-act...
This book discusses clinical advances in hepatology, with a focus on metabolic diseases and chronic ...
Hepatitis C virus (HCV) is a major cause of liver morbidity and mortality worldwide with increasing ...
Introduction: New direct-acting antivirals have changed hepatitis C virus infection management extre...
Chronic HCV infections represent a major worldwide public health problem and are responsible for a l...
Introduction: New direct-acting antiviral agents have changed the landscape of treatment of chronic ...
AbstractThe development of antiviral drugs is a very complex process. Currently, around 50 drugs hav...
Introduction: Therapeutic options for patients with HCV-related liver disease have increased over th...
The development and clinical implementation of direct-acting antivirals (DAAs) has revolutionized th...
Hepatitis C is a devastating illness which has the potential in the majority of cases to lead to sig...
Hepatitis C virus (HCV) still represents a major public health threat, with a dramatic burden from b...
com The hepatitis C virus (HCV) has a significant medical and economic impact on societies around th...
ABSTRACT Hepatitis C is a global epidemic that affects over 150 million people. The global preval...
Introduction: Management of hepatitis C virus (HCV) is rapidly changing as a result of new direct-ac...
The hepatitis C virus (HCV) has a significant medical and economic impact on societies around the wo...
One of the most exciting developments in antiviral research has been the discovery of the direct-act...
This book discusses clinical advances in hepatology, with a focus on metabolic diseases and chronic ...
Hepatitis C virus (HCV) is a major cause of liver morbidity and mortality worldwide with increasing ...
Introduction: New direct-acting antivirals have changed hepatitis C virus infection management extre...
Chronic HCV infections represent a major worldwide public health problem and are responsible for a l...
Introduction: New direct-acting antiviral agents have changed the landscape of treatment of chronic ...
AbstractThe development of antiviral drugs is a very complex process. Currently, around 50 drugs hav...
Introduction: Therapeutic options for patients with HCV-related liver disease have increased over th...
The development and clinical implementation of direct-acting antivirals (DAAs) has revolutionized th...
Hepatitis C is a devastating illness which has the potential in the majority of cases to lead to sig...
Hepatitis C virus (HCV) still represents a major public health threat, with a dramatic burden from b...
com The hepatitis C virus (HCV) has a significant medical and economic impact on societies around th...
ABSTRACT Hepatitis C is a global epidemic that affects over 150 million people. The global preval...
DOI
Add to ORKG